Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn.
We are currently seeking a dynamic, motivated, and experienced individual for the position of Thought Leader Liaison Director – Hematology (Enzomenib). This field-based role will focus on shaping the external thought leader ecosystem and pre-launch readiness for enzomenib, while also supporting the eventual transition to an in-market commercial role. The TLL will engage hematology thought leaders across academic centers...